Mounjaro e seu efeito farmacológico
Revista ft · 12.06.2026 · 30 (159) · 01-08
DOI: 10.69849/3cz4xr10 ↗Kurz gefasst
Fachartikel in der Zeitschrift Revista ft, online erschienen am 12.06.2026. Verfasst von Antônio Levy Carvalho Nobre und 2 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Mounjaro is a synthetic GLP-1 and GIP incretin drug, that has been associated with central effects on neurogenesis, neurotransmission, synaptic neuroplasticity, and neuroprotection. Brain development is a remarkable process; progenitor cells are born, differentiate, and migrate to their final locations. Axons and dendrites form important synaptic connections that prepare the brain field for encoding potentially important information for the rest of life. In the mammalian brain, synapses and receptors are overproduced and eliminated during different phases of life. Based on such references and reports, the present study was designed to describe the effect of Mounjaro on neurogenesis and neuroplasticity and to understand the neuroimmune and neuroimmunological mechanisms of action.
Zitieren
APA
Nobre, A. L. C., Guimarães, V. B. D. F., & Ribeiro, B. M. M. (2026). Mounjaro e seu efeito farmacológico. Revista ft, 30(159), 01-08. https://doi.org/10.69849/3cz4xr10
Vancouver
Nobre ALC, Guimarães VBDF, Ribeiro BMM. Mounjaro e seu efeito farmacológico. Revista ft. 2026;30(159):01-08. doi:10.69849/3cz4xr10
BibTeX
@article{Nobre2026,
author = {Nobre, Antônio Levy Carvalho and Guimarães, Vicente Bruno de Freitas and Ribeiro, Bruna Mara Machado},
title = {Mounjaro e seu efeito farmacológico},
journal = {Revista ft},
year = {2026},
volume = {30},
number = {159},
pages = {01--08},
doi = {10.69849/3cz4xr10}
}
EUVIMED